
### [NCIT:C4199](http://purl.obolibrary.org/obo/NCIT_C4199)
**Label:** Epithelial-Myoepithelial Carcinoma

**Subclasses:** [NCIT:C45545](http://purl.obolibrary.org/obo/NCIT_C45545) (Lung Epithelial-Myoepithelial Carcinoma), [NCIT:C35701](http://purl.obolibrary.org/obo/NCIT_C35701) (Salivary Gland Epithelial Myoepithelial Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36780](http://purl.obolibrary.org/obo/NCIT_C36780) (Malignant Myoepithelial Cell) 60.00%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 60.00%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) 60.00%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) 60.00%
- Thing 51.82%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) 45.36%
- [NCIT:C36769](http://purl.obolibrary.org/obo/NCIT_C36769) (Abnormal Myoepithelial Cell) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 45.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 45.36%


